Helsinn Group Announces Upcoming Presentation of Phase 3b data of NEPA (fosnetupitant / palonosetron) IV at ASCO 2019
May 31, 2019 08:00 ET
|
Helsinn Healthcare S.A.
Helsinn Group Announces Upcoming Presentation of Phase 3b data of NEPA (fosnetupitant / palonosetron) IV at ASCO 2019 The NEPA IV formulation was evaluated for safety in the AC setting. Lugano,...